Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
SOTAC
SOTAC

Sotac Pharmaceuticals Ltd.

NSE: SOTAC
SME
Sector: Healthcare
Industry: Pharmaceuticals
92.00+0.0 (+0.00%)
21 Oct, 12:00 AM

Stock Scores

Quality Score

76.5 / 100

Value Score

71.4 / 100

Price Momentum Score

6.0 / 100

QVM Score

49.5 / 100

Key Metrics

Market Cap
101.66
P/E (TTM)
17.63
P/B
1.73
P/S (TTM)
1.00
EV/EBITDA
7.72
CAPE (5Y)
20.54
ROE (TTM)
10.29
ROCE (TTM)
12.22
ROA (TTM)
4.47
Avg 3Y ROE
13.06
Earnings 3Y CAGR
8.66
Sales 3Y CAGR
20.42
Sales 5Y CAGR
15.69
Debt/Equity
0.64
Consensus TP
-
Strong Buy %
-
Promoter Holding
72.85
Pledged %
0.00

Share Price

Track Sotac Pharmaceuticals Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

1 Week returns: –
1 Month returns: –
1 Year returns: -26.40 %
Low
86.0
High
139.6
3 Year CAGR: -4.91 %
Low
86.0
High
202.8
5 Year CAGR: –
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Financial Snapshot

See detailed analysis

Multi-year trends for Sotac Pharmaceuticals Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Sotac Pharmaceuticals Ltd. Shareholding Pattern

Quarterly breakdown of Sotac Pharmaceuticals Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Sotac Pharmaceuticals Ltd. shares as reported to NSE and BSE.

Frequently Asked Questions

What is the current share price of Sotac Pharmaceuticals Ltd.?
The current share price of Sotac Pharmaceuticals Ltd. is ₹ 92.00 as of 21 Oct 2026.
What is the market capitalisation of Sotac Pharmaceuticals Ltd.?
The market capitalisation of Sotac Pharmaceuticals Ltd. stands at ₹ 101.66 Cr.
What is the PE ratio of Sotac Pharmaceuticals Ltd.?
The Price-to-Earnings (PE) ratio of Sotac Pharmaceuticals Ltd. is 17.63 as of the latest trailing twelve months data.
What is the ROE and ROCE of Sotac Pharmaceuticals Ltd.?
Sotac Pharmaceuticals Ltd. has a Return on Equity (ROE) of 10.29% and a Return on Capital Employed (ROCE) of 12.22% as per the latest financial reports.
What is the 52-week high and low of Sotac Pharmaceuticals Ltd.?
The 52-week high of Sotac Pharmaceuticals Ltd. is - and the 52-week low is -.
What is the dividend yield of Sotac Pharmaceuticals Ltd.?
The dividend yield of Sotac Pharmaceuticals Ltd. is 0.11% based on the current market price.
What is the FII and DII holding in Sotac Pharmaceuticals Ltd.?
Foreign Institutional Investors (FII) hold 16.46%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 5.60% of Sotac Pharmaceuticals Ltd. shares.
What sector does Sotac Pharmaceuticals Ltd. belong to?
Sotac Pharmaceuticals Ltd. operates in the Healthcare sector.
What is the beta of Sotac Pharmaceuticals Ltd.?
The beta of Sotac Pharmaceuticals Ltd. is 0.25, indicating its price volatility relative to the broader market.
What is the RSI of Sotac Pharmaceuticals Ltd.?
The 14-day Relative Strength Index (RSI) of Sotac Pharmaceuticals Ltd. is 35.40, placing it approaching oversold territory. An RSI above 70 is considered overbought and below 30 is considered oversold.